Fusion Antibodies Ltd (FAB) ORD GBP0.04
0.25p
(1.89%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.25p
(1.89%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.25p
(1.89%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
13.25p
13.75p
20.50p
£16.88 million
13.25p
13.00p
5.80p
n/a
0.13p (0.95%) Previous:
0.13p
271,871
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2025 | 31/03/2024 |
|---|---|---|
| Revenue (£m) | 1.96 | 1.14 |
| Profit before tax (£m) | (1.78) | (2.29) |
| Adjusted EPS (p): | (1.80) | (3.90) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Fusion Antibodies posts narrower half-year loss
24 November 2025 12:54
-
Fusion Antibodies expecting stronger second-half performance
16 October 2025 15:42
-
Fusion Antibodies reports further validation of OptiMAL platform
17 September 2025 09:42
-
Total Voting Rights
30 January 2026 17:00
-
Issue of Director Shares
27 January 2026 07:05
-
Placing and Subscription to raise approx £1.4m
27 January 2026 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.